Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharm, page-18

Don't worry about what Redchip says re price targets

IMHO and only from my perspective: the point of research reports is to try and attract cashed up bogans like me or bigger fish than me (of which there are plenty), to put their ruler over the company again and remind investors of achievements to date and milestones in the future to look forward to. Which can, and often does, create investor interest and then subsequently upon views of whether the timing is right, create buyers and higher bidders.

The thing I love most about Pharmaust is the management team, their vision/ expertise and most of all I love the fact that they are NOT trying to constantly talk themselves up like some other companies who think they're amazing. Instead they're just quiet achievers who just get on with it. And I like that a lot.

More often that not it is the company's who remain quiet achievers and the threads of companies where there aren't many posters saying "it's going to $1", that can end up being strong achievers an pleasant surprises again... All just IMHO

DYOR